General Biologicals Corporation (TPEX:4117)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
10.20
-0.25 (-2.39%)
Jul 30, 2026, 1:41 PM CST
Market Cap740.12M -22.0%
Revenue (ttm)215.74M -14.4%
Net Income465.84M
EPS7.44
Shares Out 70.83M
PE Ratio1.40
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume120,631
Open10.45
Previous Close10.45
Day's Range9.95 - 10.45
52-Week Range3.50 - 17.85
Beta0.61
Analystsn/a
Price Targetn/a
Earnings DateAug 12, 2026

About General Biologicals

General Biologicals Corporation engages in the research, development, manufacture, and sales of in-vitro diagnostics in Taiwan and internationally. It offers ELISA and chemiluminescence immunoassay, molecular and cell diagnostic, and point of care testing services. The company also provides COVID-19, digital pathology, and contract development manufacturing organization solutions; blood screening services for hepatitis and HIV; and biomaterial, such as antibody biomaterials and human plasma. Additionally, it offers a range of oral care products... [Read more]

Sector Healthcare
Founded 1984
Employees 81
Stock Exchange Taipei Exchange
Ticker Symbol 4117
Full Company Profile

Financial Performance

Financial Statements